These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36064848)

  • 21. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
    Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
    PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current aspects of hepatitis B surface antigen mutants in Singapore.
    Oon CJ; Chen WN
    J Viral Hepat; 1998 Nov; 5 Suppl 2():17-23. PubMed ID: 9857356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.
    Zhang TY; Guo XR; Wu YT; Kang XZ; Zheng QB; Qi RY; Chen BB; Lan Y; Wei M; Wang SJ; Xiong HL; Cao JL; Zhang BH; Qiao XY; Huang XF; Wang YB; Fang MJ; Zhang YL; Cheng T; Chen YX; Zhao QJ; Li SW; Ge SX; Chen PJ; Zhang J; Yuan Q; Xia NS
    Gut; 2020 Feb; 69(2):343-354. PubMed ID: 30926653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection.
    El-Mowafy M; Elegezy M; El-Mesery M; Elgaml A
    Virus Genes; 2024 Apr; 60(2):235-239. PubMed ID: 38349448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.
    Chen HB; Fang DX; Li FQ; Jing HY; Tan WG; Li SQ
    World J Gastroenterol; 2003 Feb; 9(2):304-8. PubMed ID: 12532454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape.
    Lehmann F; Slanina H; Roderfeld M; Roeb E; Trebicka J; Ziebuhr J; Gerlich WH; Schüttler CG; Schlevogt B; Glebe D
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen.
    Reyes-del Valle J; Hodge G; McChesney MB; Cattaneo R
    J Virol; 2009 Sep; 83(17):9013-7. PubMed ID: 19535451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.
    Tarafdar S; Virata ML; Yan H; Zhong L; Deng L; Xu Y; He Y; Struble E; Zhang P
    J Med Virol; 2022 Feb; 94(2):649-658. PubMed ID: 34406663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy.
    Sodhi JS; Raja W; Zargar SA; Showkat A; Parveen S; Nisar S; Wani MA; Javid G; Khan M; Aejaz S; Mohd G; Jan A; Yattoo GN; Shah A; Gulzar GM; Lone R
    Indian J Gastroenterol; 2015 Sep; 34(5):372-9. PubMed ID: 26531066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
    Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative characteristic of antigenic properties of recombinant and native hbs-antigens with G145R mutation and evaluation of their immunogenicity].
    Konopleva MV; Borisova VN; Sokolova MV; Feldsherova AA; Krymskij MA; Semenenko TA; Suslov AP
    Vopr Virusol; 2017; 62(4):179-186. PubMed ID: 29733168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.